MGO One Seven LLC Grows Holdings in Lam Research Corporation $LRCX

MGO One Seven LLC grew its position in Lam Research Corporation (NASDAQ:LRCX) by 110.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,396 shares of the semiconductor company’s stock after acquiring an additional 17,514 shares during the period. MGO One Seven LLC’s holdings in Lam Research were worth $4,472,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. IMG Wealth Management Inc. purchased a new position in shares of Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research in the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research in the second quarter valued at approximately $29,000. Delos Wealth Advisors LLC purchased a new stake in shares of Lam Research in the second quarter valued at approximately $30,000. Finally, REAP Financial Group LLC acquired a new position in shares of Lam Research during the 2nd quarter worth approximately $31,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 50,418 shares of company stock worth $7,667,305. 0.31% of the stock is owned by corporate insiders.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $220.40 on Tuesday. The firm has a 50-day simple moving average of $167.18 and a 200-day simple moving average of $134.20. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $276.83 billion, a price-to-earnings ratio of 48.55, a price-to-earnings-growth ratio of 2.52 and a beta of 1.77. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $222.58.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were issued a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company lifted their price target on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. B. Riley increased their price objective on shares of Lam Research from $180.00 to $195.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Oppenheimer set a $200.00 target price on shares of Lam Research and gave the company an “outperform” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group reissued a “buy” rating and set a $180.00 target price on shares of Lam Research in a research note on Friday. Finally, Evercore ISI raised their price target on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $167.71.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.